Hannah Weber is a co-founder of HOPO Therapeutics and Vice President of Strategy & Business Development. Hannah was formerly a Consultant with L.E.K. Consulting’s Life Sciences practice in Boston, where she managed teams in developing growth strategies for pre-commercial biotech and global pharmaceutical companies. She brings experience in launch planning for novel therapeutics, forecasting and lifecycle management of pharmaceutical pipelines, and analytic support for M&A diligences. Hannah has a lifelong passion for advancing global health and access to medicine, and has worked in pharmaceutical policy analysis for both private and nonprofit organizations.
Hannah earned her B.S. in International Health at Georgetown University, an MBA at the UC Berkeley Haas School of Business, and MPH from the UC Berkeley School of Public Health.